Literature DB >> 16107333

The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes.

Karl Balabanian1, Bernard Lagane, Simona Infantino, Ken Y C Chow, Julie Harriague, Barbara Moepps, Fernando Arenzana-Seisdedos, Marcus Thelen, Françoise Bachelerie.   

Abstract

Combined phylogenetic and chromosomal location studies suggest that the orphan receptor RDC1 is related to CXC chemokine receptors. RDC1 provides a co-receptor function for a restricted number of human immunodeficiency virus (HIV) isolates, in particular for the CXCR4-using HIV-2 ROD strain. Here we show that CXCL12, the only known natural ligand for CXCR4, binds to and signals through RDC1. We demonstrate that RDC1 is expressed in T lymphocytes and that CXCL12-promoted chemotaxis is inhibited by an anti-RDC1 monoclonal antibody. Concomitant blockade of RDC1 and CXCR4 produced additive inhibitory effects in CXCL12-induced T cell migration. Furthermore, we provide evidence that interaction of CXCL12 with RDC1 is specific, saturable, and of high affinity (apparent KD approximately 0.4 nM). In CXCR4-negative cells expressing RDC1, CXCL12 promotes internalization of the receptor and chemotactic signals through RDC1. Collectively, our data indicate that RDC1, which we propose to rename as CXCR7, is a receptor for CXCL12.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107333     DOI: 10.1074/jbc.M508234200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  400 in total

1.  Secreted CXCL12 (SDF-1) forms dimers under physiological conditions.

Authors:  Paramita Ray; Sarah A Lewin; Laura Anne Mihalko; Sasha-Cai Lesher-Perez; Shuichi Takayama; Kathryn E Luker; Gary D Luker
Journal:  Biochem J       Date:  2012-03-01       Impact factor: 3.857

2.  The CXCR7 chemokine receptor promotes B-cell retention in the splenic marginal zone and serves as a sink for CXCL12.

Authors:  Hongsheng Wang; Natalie Beaty; Sophia Chen; Chen-Feng Qi; Marek Masiuk; Dong-Mi Shin; Herbert C Morse
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

Review 3.  Cell-cell signaling interactions coordinate multiple cell behaviors that drive morphogenesis of the lateral line.

Authors:  Andy Aman; Tatjana Piotrowski
Journal:  Cell Adh Migr       Date:  2011 Nov-Dec       Impact factor: 3.405

Review 4.  CXCL12 in control of neuroinflammation.

Authors:  Miljana Momcilović; Marija Mostarica-Stojković; Djordje Miljković
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

5.  Homeostatic and tissue reparation defaults in mice carrying selective genetic invalidation of CXCL12/proteoglycan interactions.

Authors:  Patricia Rueda; Adèle Richart; Alice Récalde; Pamela Gasse; José Vilar; Coralie Guérin; Hugues Lortat-Jacob; Paulo Vieira; Franoise Baleux; Fabrice Chretien; Fernando Arenzana-Seisdedos; Jean-Sébastien Silvestre
Journal:  Circulation       Date:  2012-10-03       Impact factor: 29.690

6.  The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.

Authors:  Hengwei Zhang; Lei Yang; Xuyong Teng; Zhangyi Liu; Chenxi Liu; Lei Zhang; Zhen Liu
Journal:  Tumour Biol       Date:  2015-09-17

7.  Blocking SDF-1α/CXCR4 downregulates PDGF-B and inhibits bone marrow-derived pericyte differentiation and tumor vascular expansion in Ewing tumors.

Authors:  Randala Hamdan; Zhichao Zhou; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2013-11-26       Impact factor: 6.261

Review 8.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

9.  CXCL12 Retargeting of an Oncolytic Adenovirus Vector to the Chemokine CXCR4 and CXCR7 Receptors in Breast Cancer.

Authors:  Samia M O'Bryan; J Michael Mathis
Journal:  J Cancer Ther       Date:  2021-06

10.  A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators.

Authors:  Sandra Claes; Thomas D'huys; Anneleen Van Hout; Dominique Schols; Tom Van Loy
Journal:  J Vis Exp       Date:  2018-02-20       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.